Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy - Suda, Kenichi; Mitsudomi, Tetsuya (Translational Lung Cancer Research, 2020)